Latest Ulcerative colitis Stories
According to court documents, on June 1st, 2012, the lawsuit of Andrew Boatright v Hoffman-La Roche was removed by the defendants to federal court (case no.
Scientists from the Florida campus of The Scripps Research Institute have developed a novel technology that can identify, in animal models, potential biomarkers of ulcerative colitis, a type of inflammatory bowel disease that affects the lining of the colon.
Michigan State University researchers have unlocked secrets in bone marrow that could lead to improved treatments for colitis and Crohn’s disease.
People suffering from ulcerative colitis may be getting some new relief due to a decision by the Food and Drug Administration (FDA) to open a new drug to help alleviate symptoms.
An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis.
As Bloomberg reported on June 30th 2012, a New Jersey jury ruled that Hoffman-LaRoche must pay $18 million in damages to two former Accutane users, Kathleen Rossitto and Riley Wilkinson (case
- The act of sweetening by admixture of some saccharine substance.